These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10828795)

  • 1. Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas.
    Delorge S; Saussez S; Pelc P; Devroede B; Marchant H; Burchert M; Zeng FY; Danguy A; Salmon I; Gabius HJ; Kiss R; Hassid S
    Otolaryngol Head Neck Surg; 2000 Jun; 122(6):834-41. PubMed ID: 10828795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.
    Choufani G; Nagy N; Saussez S; Marchant H; Bisschop P; Burchert M; Danguy A; Louryan S; Salmon I; Gabius HJ; Kiss R; Hassid S
    Cancer; 1999 Dec; 86(11):2353-63. PubMed ID: 10590378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
    Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
    Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
    Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
    Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous lectins (galectins-1 and -3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and larynx.
    Plzak J; Smetana K; Betka J; Kodet R; Kaltner H; Gabius HJ
    Int J Mol Med; 2000 Apr; 5(4):369-72. PubMed ID: 10719052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
    Betka J; Plzák J; Smetana K; Gabius HJ
    Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.
    François C; van Velthoven R; De Lathouwer O; Moreno C; Peltier A; Kaltner H; Salmon I; Gabius HJ; Danguy A; Decaestecker C; Kiss R
    Am J Clin Pathol; 1999 Aug; 112(2):194-203. PubMed ID: 10439799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of galectins in head and neck squamous cell carcinoma.
    Gillenwater A; Xu XC; el-Naggar AK; Clayman GL; Lotan R
    Head Neck; 1996; 18(5):422-32. PubMed ID: 8864733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?
    Cada Z; Chovanec M; Smetana K; Betka J; Lacina L; Plzák J; Kodet R; Stork J; Lensch M; Kaltner H; André S; Gabius HJ
    Histol Histopathol; 2009 Jan; 24(1):41-8. PubMed ID: 19012243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 upregulation during tumor progression in head and neck cancer.
    Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
    Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ligands for galectins, natural galactoside-binding immunoglobulin G subfractions and sarcolectin and also of the expression of calcyclin in thyroid lesions.
    Nagy N; Decaestecker C; Dong X; Kaltner H; Schüring MP; Rocmans P; Danguy A; Gabius HJ; Kiss R; Salmon I
    Histol Histopathol; 2000 Apr; 15(2):503-13. PubMed ID: 10809372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
    Saussez S; Camby I; Toubeau G; Kiss R
    Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of expression of nuclear proteins pKi67 and p63 with lectin histochemical features in head and neck squamous cell cancer.
    Chovanec M; Smetana K; Betka J; Plzák J; Brabec J; Moya-Alvarez V; André S; Kodet R; Gabius HJ
    Int J Oncol; 2005 Aug; 27(2):409-15. PubMed ID: 16010422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-dependent glycosylation of cells in squamous cell epithelia detected by a mammalian lectin.
    Plzák J; Holíková Z; Smetana K; Dvoránková B; Hercogová J; Kaltner H; Motlík J; Gabius HJ
    Cells Tissues Organs; 2002; 171(2-3):135-44. PubMed ID: 12097836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties.
    André S; Ortega PJ; Perez MA; Roy R; Gabius HJ
    Glycobiology; 1999 Nov; 9(11):1253-61. PubMed ID: 10536041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of T-antigen-bearing neoglycoprotein and peanut agglutinin to cultured tumor cells and breast carcinomas.
    Gabius HJ; Schröter C; Gabius S; Brinck U; Tietze LF
    J Histochem Cytochem; 1990 Nov; 38(11):1625-31. PubMed ID: 2212620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?
    Fritz P; Seizer-Schmidt R; Mürdter TE; Kroemer HK; Aulitzky W; André S; Gabius HJ; Friedel G; Toomes H; Siegle I
    Acta Histochem; 1999 Jul; 101(3):239-53. PubMed ID: 10443287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
    Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.